LONDON May 1 The chief executive of
pharmaceutical company Shire declined to comment on
Thursday on any takeover interest the company may have received,
saying he could not talk about the specifics of the "M&A frenzy"
gripping the sector.
Allergan Inc, the botox maker, is preparing a
takeover approach for Dublin-based Shire, Reuters reported on
Shire's Chief Executive Flemming Ornskov also said his own
acquisition strategy was unchanged: "We are looking for
innovation, for products we can bring to market."
(Reporting by Paul Sandle, Editing by Belinda Goldsmith)